An innovative device for a more tolerable Chemotherapy
The Innovation
MERYLO’ is developing a better therapy for patients with liquid cancers. With our innovative medical device that, it will be possible to entrap the chemotherapeutical agent into the patient’s Red Blood Cells, obtaining a sustained release. The device will work directly on the patients’ own blood at their bedside. We developed a single-use kit to be used in the standard chemotherapy practice, combining the selected drug with the patient blood, thus reducing the therapy side effects.